Gladius Capital Management LP Invests $31,000 in Enhabit, Inc. (NYSE:EHAB)

Gladius Capital Management LP bought a new stake in shares of Enhabit, Inc. (NYSE:EHAB) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 3,512 shares of the company’s stock, valued at approximately $31,000.

A number of other large investors also recently modified their holdings of the business. Allspring Global Investments Holdings LLC acquired a new stake in Enhabit in the first quarter worth approximately $44,000. ProShare Advisors LLC bought a new stake in Enhabit in the first quarter worth about $118,000. Family Firm Inc. bought a new position in shares of Enhabit during the 1st quarter valued at about $124,000. Covestor Ltd grew its stake in shares of Enhabit by 1,130.0% in the 1st quarter. Covestor Ltd now owns 13,456 shares of the company’s stock worth $157,000 after purchasing an additional 12,362 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in shares of Enhabit by 13.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 16,058 shares of the company’s stock worth $166,000 after acquiring an additional 1,875 shares in the last quarter.

Wall Street Analyst Weigh In

EHAB has been the subject of a number of recent analyst reports. Leerink Partnrs raised shares of Enhabit from a “strong sell” rating to a “hold” rating in a research note on Tuesday, May 14th. SVB Leerink upgraded shares of Enhabit from an “underperform” rating to a “market perform” rating and set a $8.50 price target on the stock in a report on Tuesday, May 14th. Jefferies Financial Group downgraded Enhabit from a “buy” rating to a “hold” rating and lowered their target price for the company from $14.00 to $8.75 in a research note on Thursday, May 9th. Finally, Bank of America cut their price target on Enhabit from $9.00 to $8.00 and set an “underperform” rating for the company in a research note on Thursday, June 27th. One analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $9.35.

Enhabit Price Performance

Shares of NYSE:EHAB opened at $8.36 on Friday. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.50 and a quick ratio of 1.50. The stock has a market capitalization of $419.30 million, a P/E ratio of -5.04, a P/E/G ratio of 1.58 and a beta of 1.85. The business has a 50-day moving average of $9.13 and a two-hundred day moving average of $9.58. Enhabit, Inc. has a fifty-two week low of $7.12 and a fifty-two week high of $13.13.

Enhabit (NYSE:EHAB) last announced its earnings results on Tuesday, August 6th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.05 by $0.02. Enhabit had a positive return on equity of 1.43% and a negative net margin of 7.95%. The firm had revenue of $260.60 million during the quarter, compared to analysts’ expectations of $265.99 million. During the same quarter in the prior year, the business earned $0.04 earnings per share. On average, equities research analysts predict that Enhabit, Inc. will post 0.24 EPS for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.